Skip to main content
Erschienen in: Pediatric Nephrology 8/2006

01.08.2006 | Brief Report

Hyper-IgE syndrome and autoimmunity in Mexican children

verfasst von: Marco Yamazaki-Nakashimada, Samuel Zaltzman-Girshevich, Silvestre Garcia de la Puente, Beatriz De Leon-Bojorge, Sara Espinosa-Padilla, Marimar Saez-de-Ocariz, Daniel Carrasco-Daza, Victor Hernandez-Bautista, Lorenzo Pérez-Fernandez, Francisco Espinosa-Rosales

Erschienen in: Pediatric Nephrology | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Hyper-IgE syndrome (HIES) is a primary immunodeficiency characterized by recurrent skin abscesses, recurrent pneumonia with pneumatocele formation, eczema, eosinophilia, and elevated levels of serum IgE. Patients with the autosomal recessive (AR) form of HIES appear to be prone to developing autoimmune diseases. We present two cases of HIES with autoimmune complications; one case was a product of a consanguineous marriage, the other one was a sporadic case. The first patient presented with recurrent episodes of erythema nodosum, warts, bronchiolitis obliterans and thrombocytopenia. The second patient developed glomerulonephritis resulting in endstage renal failure. She later developed malar rash, oral ulcers, cerebral infarcts with vasculitis and positive ANA, anti-dsDNA, and antiphospholipid antibodies. We discuss the dilemma in treating patients who present with both primary immunodeficiency and autoimmunity.
Literatur
1.
Zurück zum Zitat Buckley RH, Wray BB, Belmaker EZ (1972) Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49:59-70PubMed Buckley RH, Wray BB, Belmaker EZ (1972) Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49:59-70PubMed
2.
Zurück zum Zitat Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O’Connell AC, Puck JM (1999) Hyper-IgE syndrome with recurrent infections- an autosomal dominant multisystemic disorder. N Engl J Med 340:692–702CrossRef Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O’Connell AC, Puck JM (1999) Hyper-IgE syndrome with recurrent infections- an autosomal dominant multisystemic disorder. N Engl J Med 340:692–702CrossRef
3.
Zurück zum Zitat Grimbacher B, Schaffer A, Holland SM, Davis J, Gallin JI, Malech HL, Atkinson P, Belohradsky BH, Buckley RH, Cossu F, Español T, Garty BZ, Matamoros N, Myers LA, Nelson RP, Ochs H, Renner ED, Wellinghausen N, Puck JM (1999) Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 65:735–744CrossRef Grimbacher B, Schaffer A, Holland SM, Davis J, Gallin JI, Malech HL, Atkinson P, Belohradsky BH, Buckley RH, Cossu F, Español T, Garty BZ, Matamoros N, Myers LA, Nelson RP, Ochs H, Renner ED, Wellinghausen N, Puck JM (1999) Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 65:735–744CrossRef
4.
Zurück zum Zitat Renner ED, Puck J, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M, Davis J, Belohradsky BH, Grimbacher B (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93–99CrossRef Renner ED, Puck J, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M, Davis J, Belohradsky BH, Grimbacher B (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93–99CrossRef
5.
Zurück zum Zitat Grimbacher B, Holland SM, Puck J (2005) Hyper-IgE syndromes. Immunol Rev 203:244–250CrossRef Grimbacher B, Holland SM, Puck J (2005) Hyper-IgE syndromes. Immunol Rev 203:244–250CrossRef
6.
Zurück zum Zitat Schopfer K, Feldges A, Baerlocher K, Parisot RF, Wilhelm JA, Matter L (1983) Systemic lupus erythematosus in Staphylococcus aureus hyperimmunoglobulinaemia E syndrome. Br Med J (Clin Res Ed) 287:524–526CrossRef Schopfer K, Feldges A, Baerlocher K, Parisot RF, Wilhelm JA, Matter L (1983) Systemic lupus erythematosus in Staphylococcus aureus hyperimmunoglobulinaemia E syndrome. Br Med J (Clin Res Ed) 287:524–526CrossRef
7.
Zurück zum Zitat North J, Kotecha S, Houtman P, Whaley K (1997) Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol 36:297–298CrossRef North J, Kotecha S, Houtman P, Whaley K (1997) Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol 36:297–298CrossRef
8.
Zurück zum Zitat Brugnoni D, Franceschini F, Airo P, Cattaneo R (1998) Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins. Br J Rheumatol 37:807–808CrossRef Brugnoni D, Franceschini F, Airo P, Cattaneo R (1998) Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins. Br J Rheumatol 37:807–808CrossRef
9.
Zurück zum Zitat Leyh F, Wendt V, Scherer R (1986) Systemic lupus erythematosus and hyper-IgE syndrome in a 13-year-old child. Z Hautkr 61:611–614PubMed Leyh F, Wendt V, Scherer R (1986) Systemic lupus erythematosus and hyper-IgE syndrome in a 13-year-old child. Z Hautkr 61:611–614PubMed
10.
Zurück zum Zitat Bong CN, Huang SC, Wang CL, Liu PM, Chen HH, Yang KD (2005) Cyclosporin A therapy in a case with hyperimmunoglobulin E and nephrotic syndrome. J Microbiol Immunol Infect 1:60–64 Bong CN, Huang SC, Wang CL, Liu PM, Chen HH, Yang KD (2005) Cyclosporin A therapy in a case with hyperimmunoglobulin E and nephrotic syndrome. J Microbiol Immunol Infect 1:60–64
11.
Zurück zum Zitat Tanji C, Yorioka N, Kanahara K (1999) Hyperimmunoglobulin E syndrome associated with nephrotic syndrome. Intern Med 38:491–494CrossRef Tanji C, Yorioka N, Kanahara K (1999) Hyperimmunoglobulin E syndrome associated with nephrotic syndrome. Intern Med 38:491–494CrossRef
12.
Zurück zum Zitat Ozarmagan G, Didem Yazganoglu K, Agacfidan A (2005) Hyper-IgE syndrome with widespread premalign oral papillomas treated with interferon alpha2b. Acta Derm Venereol 85:433–435CrossRef Ozarmagan G, Didem Yazganoglu K, Agacfidan A (2005) Hyper-IgE syndrome with widespread premalign oral papillomas treated with interferon alpha2b. Acta Derm Venereol 85:433–435CrossRef
13.
Zurück zum Zitat Sehrt P, Zielen S, Gerein V, Herrmann G, Hofmann D (1999) Hyper-IgE syndrome- two case reports of unusual complications. Immun Infekt 22:156–157 Sehrt P, Zielen S, Gerein V, Herrmann G, Hofmann D (1999) Hyper-IgE syndrome- two case reports of unusual complications. Immun Infekt 22:156–157
14.
Zurück zum Zitat Clark TJ, Herod JJ, Kehoe S, Luesley DM (1998) The development of invasive vulvar cancer in a patient with Job’s syndrome, a rare immunodeficient condition. Br J Obstet Gynaecol 105:468–470CrossRef Clark TJ, Herod JJ, Kehoe S, Luesley DM (1998) The development of invasive vulvar cancer in a patient with Job’s syndrome, a rare immunodeficient condition. Br J Obstet Gynaecol 105:468–470CrossRef
15.
Zurück zum Zitat Deerojanawong J, Chang AB, Eng PA, Robertson CF, Kemp AS (1997) Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome. Pediatr Pulmonol 24:324–330CrossRef Deerojanawong J, Chang AB, Eng PA, Robertson CF, Kemp AS (1997) Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome. Pediatr Pulmonol 24:324–330CrossRef
16.
Zurück zum Zitat Soto Campos JG, Cano Gomez S, Capote Gil F (1997) Bronchiolitis obliterans organizing pneumonia in common variable immunodeficiency. Arch Bronconeumol 33:548CrossRef Soto Campos JG, Cano Gomez S, Capote Gil F (1997) Bronchiolitis obliterans organizing pneumonia in common variable immunodeficiency. Arch Bronconeumol 33:548CrossRef
17.
Zurück zum Zitat Ito M, Nakagawa A, Hirabayashi N, Asai J (1997) Bronchiolitis obliterans in ataxia-telangiectasia. Virchows Arch 430:131–137CrossRef Ito M, Nakagawa A, Hirabayashi N, Asai J (1997) Bronchiolitis obliterans in ataxia-telangiectasia. Virchows Arch 430:131–137CrossRef
18.
Zurück zum Zitat Zahraa J, Herold B, Abrahams C, Johnson D (1996) Bronchiolitis obliterans organizing pneumonia in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 15:448–451CrossRef Zahraa J, Herold B, Abrahams C, Johnson D (1996) Bronchiolitis obliterans organizing pneumonia in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 15:448–451CrossRef
19.
Zurück zum Zitat Kuzmanovska DB, Sahpazova EM, Grujovska SJ, Trajkovski Z (2004) Renal infarction in a child with systemic lupus erythematosus. Pediatr Nephrol 19:685–687CrossRef Kuzmanovska DB, Sahpazova EM, Grujovska SJ, Trajkovski Z (2004) Renal infarction in a child with systemic lupus erythematosus. Pediatr Nephrol 19:685–687CrossRef
20.
Zurück zum Zitat Arkwright PD, Abinun M, Cant AJ (2002) Autoimmunity in human primary immunodeficiency diseases. Blood 99:2694–2702CrossRef Arkwright PD, Abinun M, Cant AJ (2002) Autoimmunity in human primary immunodeficiency diseases. Blood 99:2694–2702CrossRef
21.
Zurück zum Zitat Etzioni A (2003) Immunedeficiency and autoimmunity. Autoimmun Rev 2:364–369CrossRef Etzioni A (2003) Immunedeficiency and autoimmunity. Autoimmun Rev 2:364–369CrossRef
22.
Zurück zum Zitat Ito R, Mori M, Katakura S, Kobayashi N, Naruto T, Osamura Y, Aihara Y, Yokota S (2003) Selective insufficiency of IFN-γ secretion in patients with hyper-IgE syndrome. Allergy 58:329–336CrossRef Ito R, Mori M, Katakura S, Kobayashi N, Naruto T, Osamura Y, Aihara Y, Yokota S (2003) Selective insufficiency of IFN-γ secretion in patients with hyper-IgE syndrome. Allergy 58:329–336CrossRef
23.
Zurück zum Zitat Verthelyi D, Klinman DM (1999) Balance between type 1 and type 2 cytokine-secreting cells: impact on disease activity in systemic lupus erythematosus. In: Kammer GM, Tsokos GC (eds) Lupus: Molecular and cellular pathogenesis. Humana, Totowa, NJ Verthelyi D, Klinman DM (1999) Balance between type 1 and type 2 cytokine-secreting cells: impact on disease activity in systemic lupus erythematosus. In: Kammer GM, Tsokos GC (eds) Lupus: Molecular and cellular pathogenesis. Humana, Totowa, NJ
24.
Zurück zum Zitat Elkayam O, Tamir R, Pick AI, Wysenbeek A (1995) Serum IgE concentrations, disease activity and atopic disorders in systemic lupus erythematosus. Allergy 50:94–96PubMed Elkayam O, Tamir R, Pick AI, Wysenbeek A (1995) Serum IgE concentrations, disease activity and atopic disorders in systemic lupus erythematosus. Allergy 50:94–96PubMed
25.
Zurück zum Zitat Laurent J, Lagrue G, Sobel A (1986) Increased serum IgE levels in patients with lupus nephritis (letter). Am J Nephrol 6:413–414CrossRef Laurent J, Lagrue G, Sobel A (1986) Increased serum IgE levels in patients with lupus nephritis (letter). Am J Nephrol 6:413–414CrossRef
26.
Zurück zum Zitat Tuma SN, Llach FF, Sostrin S, Dubois EL, Massry SG (1981) Glomerular IgE deposits in patients with lupus nephritis. Am J Nephrol 1:31–36CrossRef Tuma SN, Llach FF, Sostrin S, Dubois EL, Massry SG (1981) Glomerular IgE deposits in patients with lupus nephritis. Am J Nephrol 1:31–36CrossRef
27.
Zurück zum Zitat Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, Kobrynski LJ, Levinson AI, Mazer B, Nelson RP Jr, Orange JS, Routes JM, Shearer WT, Sorensen RU; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology (2005) Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94 (Suppl 1):S1–63CrossRef Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, Kobrynski LJ, Levinson AI, Mazer B, Nelson RP Jr, Orange JS, Routes JM, Shearer WT, Sorensen RU; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology (2005) Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94 (Suppl 1):S1–63CrossRef
28.
Zurück zum Zitat Fountain NB, Lopes MB (1999) Control of primary angiitis of the CNS associated with cerebral amyloid angiopathy by cyclophosphamide alone. Neurology 52:660–662CrossRef Fountain NB, Lopes MB (1999) Control of primary angiitis of the CNS associated with cerebral amyloid angiopathy by cyclophosphamide alone. Neurology 52:660–662CrossRef
29.
Zurück zum Zitat Baca V, Lavalle C, Garcia R, Catalan T, Sauceda JM, Sanchez G, Martinez T, Ramirez ML, Marquez LM, Rojas JC (1999) Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 26:432–439PubMed Baca V, Lavalle C, Garcia R, Catalan T, Sauceda JM, Sanchez G, Martinez T, Ramirez ML, Marquez LM, Rojas JC (1999) Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 26:432–439PubMed
30.
Zurück zum Zitat Beimler JHM, Andrassy F (2004) Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis: How long? How much? Pediatr Nephrol 19:949–955CrossRef Beimler JHM, Andrassy F (2004) Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis: How long? How much? Pediatr Nephrol 19:949–955CrossRef
31.
Zurück zum Zitat Etzioni A, Shehadeh N, Brecher A, Yorman S, Pollack S (1997) Cyclosporin A in hyperimmunoglobulin E syndrome. Ann Allergy Asthma Immunol 78:413–414CrossRef Etzioni A, Shehadeh N, Brecher A, Yorman S, Pollack S (1997) Cyclosporin A in hyperimmunoglobulin E syndrome. Ann Allergy Asthma Immunol 78:413–414CrossRef
32.
Zurück zum Zitat Lepore L, Kiren V (2000) Autologous bone marrow transplantation versus alternative drugs in pediatric rheumatic diseases. Haematologica 85(Suppl 11):89–92PubMed Lepore L, Kiren V (2000) Autologous bone marrow transplantation versus alternative drugs in pediatric rheumatic diseases. Haematologica 85(Suppl 11):89–92PubMed
33.
Zurück zum Zitat Gennery AR, Flood TJ, Abinun M, Cant AJ (2000) Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 25:1303–1305CrossRef Gennery AR, Flood TJ, Abinun M, Cant AJ (2000) Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 25:1303–1305CrossRef
34.
Zurück zum Zitat Wakim M, ALazard M, Yajima A, Speights D, Saxon A, Stiehm ER (1998) High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 81:153–158CrossRef Wakim M, ALazard M, Yajima A, Speights D, Saxon A, Stiehm ER (1998) High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 81:153–158CrossRef
Metadaten
Titel
Hyper-IgE syndrome and autoimmunity in Mexican children
verfasst von
Marco Yamazaki-Nakashimada
Samuel Zaltzman-Girshevich
Silvestre Garcia de la Puente
Beatriz De Leon-Bojorge
Sara Espinosa-Padilla
Marimar Saez-de-Ocariz
Daniel Carrasco-Daza
Victor Hernandez-Bautista
Lorenzo Pérez-Fernandez
Francisco Espinosa-Rosales
Publikationsdatum
01.08.2006
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 8/2006
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0178-3

Weitere Artikel der Ausgabe 8/2006

Pediatric Nephrology 8/2006 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.